Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: A phase 3 trial (
CALGB 9583).
Impact of Physical Activity on Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from
CALGB 89803.
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of
CALGB 59909.
Sugar-sweetened beverage intake and cancer recurrence and survival in
CALGB 89803 (Alliance).
The Breakthrough designation is primarily based upon the positive results from the Phase HI RATIFY (
CALGB 10603) clinical trial.
Overall, 22% of the women were deemed by investigators to be eligible for no radiotherapy because they fit the criteria laid out in the
CALGB (Cancer and Leukemia Group B) 9493 study: age 70 years or older, with T1N0, estrogen receptor-positive disease.
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma:
CALGB 30406 trial.
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from
CALGB 9342.
(2006) (16) found in an analysis of the Intergroup
CALGB study, that physically active patients with bowel cancer had 35% reduction in relapse rate in after chemotherapy.
Phase II trial of galiximab plus rituximab (
CALGB trial) in untreated follicular lymphoma showed that the ORR was 72.1% including a 47.6% CR rate [100].
Socinski et al., "Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma:
CALGB 30406 trial," Journal of Clinical Oncology, vol.
More recently, the predictive power of hypertension was evaluated in a retrospective analysis of the phase III
CALGB 90206 study, which demonstrated that patients on bevacizumab plus interferon who developed grade [greater than or equal to] 2 hypertension had significantly greater progression-free survival and overall survival times than patients who did not develop hypertension [23].